Trademark Overview
On Thursday, April 18, 2024, a trademark application was filed for ELSA with the United States Patent and Trademark Office. The USPTO has given the ELSA trademark a serial number of 98507838. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, November 6, 2024. This trademark is owned by Fosun Pharma USA Inc.. The ELSA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the treatment of central nervous system diseases, neuromuscular diseases, metabolic diseases, and diseases related to RNA processing and translation
Biochemical research and development; Biotechnology research; Gene therapy research; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the field of RNA-targeted drugs; Research and development in the field of nucleic acids, biologics, central nervous system diseases, metabolic diseases, and small molecule drugs; Research and development in the field of gene therapy, namely, using knowledge of the RNA transcript splicing regulation machinery to improve efficacy; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
